Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 183.00
Bid: 183.00
Ask: 184.00
Change: -4.80 (-2.56%)
Spread: 1.00 (0.546%)
Open: 190.00
High: 190.00
Low: 181.80
Prev. Close: 187.80
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

19 Jun 2015 07:01

RNS Number : 6523Q
PureTech Health plc
19 June 2015
 



NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO, OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR IN TO ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL

 

PURETECH HEALTH PLC

 

Stabilisation Notice

 

19 June 2015

 

Jefferies International Limited (contact: Lee Morton; telephone: +44 (0)20 7029 8753, Luca Erpici; telephone: +44 (0)20 7029 8415) hereby gives notice that it, and its affiliates, may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

 

Issuer:

 

PureTech Health plc

Shares:

 

Ordinary Shares of one pence each in the capital of PureTech Health plc (ISIN: GB00BY2Z0H74)

 

Offering size:

 

67,599,621 new Ordinary Shares

Offer price:

 

160 pence per Share

Stabilisation:

 

Stabilising Manager:

 

Jefferies International Limited, Vintners Place, 68 Upper Thames Street, London EC4V 3BJ

Stabilisation period expected to start on:

 

8:00am on 19 June 2015

Stabilisation period expected to end no later than:

 

17 July 2015

Maximum size of over-allotment facility:

 

10,139,943 Ordinary Shares

Over-allotment Option:

 

Terms:

PureTech Health plc has granted to Jefferies International Limited, in its capacity as stabilising manager, the option to acquire up to an additional 10,139,943 Ordinary Shares (representing 15 per cent. of the new Ordinary Shares to be issued by PureTech Health plc in the offering)

 

Duration:

This option may be exercised by the Stabilising Manager in whole or in one or more parts, on one or more occasions at any time from 19 June 2015 to 17 July 2015

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting, stabilising or maintaining the market price of the securities at a level higher than that which might otherwise prevail in the open market. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time without prior notice. Any stabilisation action shall be carried out in accordance with all applicable rules and regulations.

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

 

This announcement and copies of this announcement are not being made and may not be distributed, published, or sent, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, South Africa or Japan or to any persons in any of those jurisdictions or any other jurisdictions where to do so would be unlawful or would require registration or other measures.

 

The Offer and the distribution of this announcement and other information in connection with the listing and Offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not and does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction where such an offer would be unlawful.

 

The Securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable laws of any state or other jurisdiction of the United States. The securities are being offered and sold outside the United States in offshore transactions as defined in, and in compliance with, Regulation S under the US Securities Act. The Company does not intend to register any part of the Offer in the United States and there will be no public offering of securities in the United States.

 

The Securities have not been and will not be registered under the applicable securities laws of Canada, Japan, South Africa or Australia and may not be offered or sold in Canada, Japan, South Africa or Australia except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the applicable securities laws. There will be no public offering of securities in Canada, Japan, South Africa or Australia.

 

This announcement is only addressed to, and directed at, persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Directive" means Directive 2003/71/EC (as amended) and includes any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at, Qualified Investors (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who are high net worth companies, unincorporated associations and partnerships and trustees of high value trusts or other persons to whom it may otherwise lawfully be communicated falling within Article 49(2)(a)-(d) of the Order, (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to and will only be engaged in with such persons. This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons; and (ii) in any member state of the European Economic Area other than the United Kingdom, by persons who are not Qualified Investors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASKNFSFSEEF
Date   Source Headline
27th Jun 20245:01 pmRNSPDMR Notification RSU Vesting
27th Jun 20245:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:00 pmRNSCompletion of Tender Offer & Total Voting Rights
24th Jun 20247:00 amRNSResult of Tender Offer
20th Jun 20247:00 amRNSDirector Declaration
13th Jun 20245:42 pmRNSResult of AGM
7th Jun 20245:30 pmRNSHolding(s) in Company
6th Jun 20245:34 pmRNSResult of Meeting
4th Jun 20247:00 amRNSAdditional Disclosure Re: Tender Offer
3rd Jun 20247:00 amRNSTotal Voting Rights
29th May 20241:04 pmRNSPRTC's Akili Enters Into Merger Agreement
23rd May 202412:00 pmRNSPRTC to Present at Jefferies Healthcare Conference
21st May 202412:05 pmRNSPRTC's Vedanta Begins Phase 3 of VE303 in C. diff
20th May 20247:00 amRNSTender Offer
9th May 202412:05 pmRNSPRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data
7th May 202412:05 pmRNSPRTC's Seaport Announces Board/Team Appointments
1st May 20247:00 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.